GI
WST icon

GAMMA Investing’s West Pharmaceutical WST Stock Holding History

GAMMA Investing’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.83M Buy
4,935
+840
+21% +$297K 0.06% 243
2026
Q2 		$1.47M Buy
4,095
+674
+20% +$206K 0.05% 287
2026
Q1 		$857K Buy
3,421
+840
+33% +$209K 0.04% 391
2025
Q4 		$710K Buy
2,581
+424
+20% +$116K 0.04% 415
2025
Q3 		$566K Buy
2,157
+743
+53% +$181K 0.03% 470
2025
Q2 		$309K Buy
1,414
+784
+124% +$168K 0.02% 662
2025
Q1 		$141K Sell
630
-668
-51% -$184K 0.01% 975
2024
Q4 		$425K Buy
1,298
+440
+51% +$138K 0.04% 406
2024
Q3 		$258K Buy
858
+309
+56% +$94.6K 0.03% 523
2024
Q2 		$181K Sell
549
-43
-7% -$15.2K 0.02% 526
2024
Q1 		$234K Buy
592
+180
+44% +$66.6K 0.05% 348
2023
Q4 		$154K Buy
+412
New +$146K 0.04% 388

Other funds holding WST

BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
BWM
Biltmore Wealth Management Tempe, Arizona $323M AUM 13.82% 1-Year Est. Return
RFA
RTD Financial Advisors Philadelphia, Pennsylvania $914M AUM 11.18% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $425M AUM 14.36% 1-Year Est. Return

GAMMA Investing's WST Position: Q3 2026 in Review

GAMMA Investing increased its West Pharmaceutical (WST) stake by 21% in Q3 2026, buying an estimated $297K and bringing the position to 4,935 shares worth $1.83M. The position accounts for 0.06% of the portfolio, ranked #243.

GAMMA Investing first reported a position in WST in Q4 2023 and has held it in 12 quarters since. 29 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • GAMMA Investing held 4,935 shares of West Pharmaceutical worth $1.83M as of Q3 2026.
  • GAMMA Investing bought 840 West Pharmaceutical shares in Q3 2026, an estimated $297K.
  • West Pharmaceutical made up 0.06% of GAMMA Investing's portfolio in Q3 2026, its #243 holding.
  • GAMMA Investing first reported a position in West Pharmaceutical in Q4 2023 and has held it in 12 quarters since.
  • 29 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.